Lupus & antiphospholipid syndrome

Type I Interferon Drives Dysfunction of a Distinct CD8 + HLA ‐ DRB1 + T Cell Subset in Systemic Lupus Erythematosus

Arthritis RheumatolPublished Mechanistic study

Authors' conclusion

CD8+ HLA-DRB1+ T cells represent a dysfunctional effector memory and proliferative population expanded in SLE. Type I IFN drives this paradoxical state by promoting exhaustion and impairing degranulation.

Study context

Population
Peripheral blood CD8+ T cells from patients with systemic lupus erythematosus (SLE) and healthy controlsscRNA-seq: 6 SLE, 6 matched controls
Participants
11 vs 12
Comparison
SLE vs healthy controls
  • SLEn = 11
  • Healthy controlsn = 12reference
Outcome
CD8+ HLA-DRB1+ T cells
Methodological detailsflow cytometry, single-cell RNA sequencing, T cell receptor sequencing, IFNα stimulation
  • Flow cytometry
  • Single-cell RNA sequencing
  • T cell receptor sequencing
  • IFNα stimulation

Main finding

As reported in the abstract

  • Enriched within effector memory, CD45RA+ effector memory and proliferative CD8+ T cells; significantly expanded within effector memory and proliferative compartment in SLE vs healthy controls
  • Paradoxical features of cytotoxicity, proliferation, exhaustion and senescence
  • Lupus cells vs healthy controls: increased exhaustion, reduced cytotoxicity, impaired antiviral pathways
  • IFNα enhanced IFNγ responses and exacerbated exhaustion and senescence in lupus CD8+ HLA-DRB1+ T cells
  • IFNα reduced CD107a surface mobilization (impaired degranulation) despite up-regulated cytotoxic gene expression
  • Most kidney-infiltrating CD8+ T cells in LN data sets are HLA-DRB1+
  • HLA-DRB1 expression on peripheral CD8+ T cells in SLE positively correlated with SLEDAI scores

Original publication

Type I Interferon Drives Dysfunction of a Distinct CD8 + HLA ‐ DRB1 + T Cell Subset in Systemic Lupus Erythematosus. Arthritis Rheumatol. Published 10 August 2026. doi:10.1002/art.70292

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.